Decera Clinical Education Neuroscience Podcast · Decera Clinical Education

Inpatient Treatment of Severe COVID-19 in Patients Who Are Immunocompromisedn People Who Are Immunocompromised

·15 min·1 clip

Immunocompromised patients accounted for 24% of COVID-19 deaths despite being only 3.9% of the study population.

This educational podcast episode features a roundtable discussion with three infectious disease experts on managing severe COVID-19 in hospitalized immunocompromised patients. They analyze the disproportionate burden of disease in this population, walk through a detailed clinical case, and review assessment strategies and treatment guidelines based on the latest evidence.

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Decera Clinical Education Neuroscience Podcast